Earnings Reaction: ON Semiconductor Misses Estimates, Tyson Foods Exceeds

ON Semiconductor Corporation (ON) shares plummeted 15.6% after reporting Q2 2025 earnings of $0.53 per share, missing the Zacks Consensus Estimate of $0.54 per share. Tyson Foods (TSN) shares gained 2.4% after reporting Q3 fiscal 2025 earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.72 per share. Wayfair (W) shares surged 12.7% after reporting Q2 2025 earnings of $0.87 per share, surpassing the Zacks Consensus Estimate of $0.36 per share. TG Therapeutics (TGTX) shares tumbled 18% after reporting Q2 2025 earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.32 per share.

ON Semiconductor Corporation (ON) reported a quarterly earnings surprise of -1.85% in Q2 2025, with earnings of $0.53 per share, missing the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $0.96 per share a year ago. The company's shares lost about 15.6% since the beginning of the year, compared to the S&P 500's gain of 6.1%. Over the last four quarters, ON Semiconductor has surpassed consensus EPS estimates two times. Revenue for the quarter ended June 2025 was $1.47 billion, surpassing the Zacks Consensus Estimate by 1.30% [1].

Tyson Foods, Inc. (TSN) shares gained 2.4% after reporting Q3 fiscal 2025 earnings of $0.91 per share, beating the Zacks Consensus Estimate of $0.72 per share. The company's revenue of $13.884 billion rose 4% year over year, surpassing the Zacks Consensus Estimate of $13.628 billion. Gross profit in the quarter was $1.1 billion, up from $878 million reported in the year-ago period. The company's shares have lost 2.6% in the past three months compared to the industry's drop of 2.2% [2].

Wayfair Inc. (W) shares surged 12.7% after reporting Q2 2025 earnings of $0.87 per share, surpassing the Zacks Consensus Estimate of $0.36 per share. The company's revenue of $1.6 billion rose 18% year over year, surpassing the Zacks Consensus Estimate of $1.4 billion. The company's shares have gained 15.6% since the beginning of the year, compared to the S&P 500's gain of 6.1% [3].

TG Therapeutics, Inc. (TGTX) shares tumbled 18% after reporting Q2 2025 earnings of $0.17 per share, missing the Zacks Consensus Estimate of $0.32 per share. The company's revenue of $133.4 million rose 11% year over year, surpassing the Zacks Consensus Estimate of $126.6 million. The company's shares have lost 18.4% since the beginning of the year, compared to the S&P 500's gain of 6.1% [4].

References:
[1] https://finance.yahoo.com/news/semiconductor-corp-q2-earnings-miss-131001115.html
[2] https://finance.yahoo.com/news/tyson-foods-q3-earnings-beat-173400601.html
[3] https://simplywall.st/stocks/us/food-beverage-tobacco/nyse-tsn/tyson-foods/news/tyson-foods-third-quarter-2025-earnings-revenues-beat-expect
[4] https://finance.yahoo.com/news/tg-therapeutics-q2-earnings-miss-131001115.html